Identification of new antibacterial agents that inhibit type III secretion. The development of new antibacterial drugs is an unmet global health priority. This project will investigate several plant-derived compounds that have been found to display promising antibacterial activity. This project has the potential to identify compounds that may result in a new antibiotic therapy.
New drugs against parasitic nematodes of livestock animals. New drugs against parasitic nematodes of livestock animals. This project aims to develop an innovative technology platform to deliver novel anti-infectives as biotechnological outcomes, using postgenomics, computing and chemistry. Advanced molecular, computer and chemistry technologies provide unprecedented opportunities to design radically new interventions against socioeconomically important infectious diseases affecting billions of a ....New drugs against parasitic nematodes of livestock animals. New drugs against parasitic nematodes of livestock animals. This project aims to develop an innovative technology platform to deliver novel anti-infectives as biotechnological outcomes, using postgenomics, computing and chemistry. Advanced molecular, computer and chemistry technologies provide unprecedented opportunities to design radically new interventions against socioeconomically important infectious diseases affecting billions of animals worldwide. Anticipated outcomes are the design of radically new chemotherapies to control parasitic diseases, the translation of fundamental research into biotechnological outcomes, international visibility of Australian science, and a solid skills- and knowledge-base in veterinary drug development.Read moreRead less
New anti-parasitic drugs for a global veterinary market. This project aims to establish an advanced, industry-linked pipeline for the development of new drugs against resilient infectious agents (parasites) that cause serious diseases in billions of animals worldwide. The research expects to discover new ways of killing parasites that survive in their host animal, despite being under severe attack by the host immune system. The resultant shift in fundamental understanding will lead to innovative ....New anti-parasitic drugs for a global veterinary market. This project aims to establish an advanced, industry-linked pipeline for the development of new drugs against resilient infectious agents (parasites) that cause serious diseases in billions of animals worldwide. The research expects to discover new ways of killing parasites that survive in their host animal, despite being under severe attack by the host immune system. The resultant shift in fundamental understanding will lead to innovative technologies or products to ameliorate the burden of parasites in livestock animals. Expected socioeconomic benefits include commercial products for end-users and lifting Australia’s scientific knowledge base, reputation in biotechnology, livestock production and investment in translational research.Read moreRead less